| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0483 |
| Trial ID | NCT03953599 |
| Disease | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19-STAR-T cells |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | CD19-STAR-T for Patients With B Cell Malignancies |
| Year | 2019 |
| Country | China |
| Company sponsor | Hebei Yanda Ludaopei Hospital |
| Other ID(s) | HXYT-003 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||